
Malgorzata A. Walicka
Examiner (ID: 13681)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 345 |
| Issued Applications | 187 |
| Pending Applications | 28 |
| Abandoned Applications | 130 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 363331
[patent_doc_number] => 07482141
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-27
[patent_title] => 'Methods and compositions for vitamin K epoxide reductase'
[patent_app_type] => utility
[patent_app_number] => 11/699930
[patent_app_country] => US
[patent_app_date] => 2007-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 8
[patent_no_of_words] => 10651
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/482/07482141.pdf
[firstpage_image] =>[orig_patent_app_number] => 11699930
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/699930 | Methods and compositions for vitamin K epoxide reductase | Jan 29, 2007 | Issued |
Array
(
[id] => 856660
[patent_doc_number] => 07374918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-20
[patent_title] => 'Modified sarcosine oxidases, genes and recombinant DNAs thereof, and methods for preparing the same'
[patent_app_type] => utility
[patent_app_number] => 11/627484
[patent_app_country] => US
[patent_app_date] => 2007-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4000
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/374/07374918.pdf
[firstpage_image] =>[orig_patent_app_number] => 11627484
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/627484 | Modified sarcosine oxidases, genes and recombinant DNAs thereof, and methods for preparing the same | Jan 25, 2007 | Issued |
Array
(
[id] => 5625347
[patent_doc_number] => 20060263852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'ASP2'
[patent_app_type] => utility
[patent_app_number] => 11/476286
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8858
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263852.pdf
[firstpage_image] =>[orig_patent_app_number] => 11476286
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/476286 | ASP2 | Jun 27, 2006 | Abandoned |
Array
(
[id] => 5608023
[patent_doc_number] => 20060269539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'ASP2'
[patent_app_type] => utility
[patent_app_number] => 11/476984
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8856
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269539.pdf
[firstpage_image] =>[orig_patent_app_number] => 11476984
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/476984 | ASP2 | Jun 27, 2006 | Abandoned |
Array
(
[id] => 5785305
[patent_doc_number] => 20060205018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Novel human enzymes of the metalloprotease family'
[patent_app_type] => utility
[patent_app_number] => 11/433388
[patent_app_country] => US
[patent_app_date] => 2006-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20896
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205018.pdf
[firstpage_image] =>[orig_patent_app_number] => 11433388
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/433388 | Human enzymes of the metalloprotease family | May 14, 2006 | Issued |
Array
(
[id] => 5677804
[patent_doc_number] => 20060183160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Novel beta-secretase and modulation of beta-secretase activity'
[patent_app_type] => utility
[patent_app_number] => 11/403512
[patent_app_country] => US
[patent_app_date] => 2006-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15756
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183160.pdf
[firstpage_image] =>[orig_patent_app_number] => 11403512
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/403512 | Novel beta-secretase and modulation of beta-secretase activity | Apr 11, 2006 | Abandoned |
Array
(
[id] => 7692179
[patent_doc_number] => 20070231854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Mutant carotenoid ketolase'
[patent_app_type] => utility
[patent_app_number] => 11/395644
[patent_app_country] => US
[patent_app_date] => 2006-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11636
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231854.pdf
[firstpage_image] =>[orig_patent_app_number] => 11395644
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/395644 | Mutant carotenoid ketolase | Mar 30, 2006 | Issued |
Array
(
[id] => 5843460
[patent_doc_number] => 20060121588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Process for the biological production of 1,3-propanediol with high titer'
[patent_app_type] => utility
[patent_app_number] => 11/282993
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27796
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121588.pdf
[firstpage_image] =>[orig_patent_app_number] => 11282993
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/282993 | Process for the biological production of 1,3-propanediol with high titer | Feb 12, 2006 | Issued |
Array
(
[id] => 5912910
[patent_doc_number] => 20060127972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'In vivo production of cephalosporins'
[patent_app_type] => utility
[patent_app_number] => 11/349381
[patent_app_country] => US
[patent_app_date] => 2006-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6279
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127972.pdf
[firstpage_image] =>[orig_patent_app_number] => 11349381
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/349381 | In vivo production of cephalosporins | Feb 6, 2006 | Abandoned |
Array
(
[id] => 5851137
[patent_doc_number] => 20060234328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Anthrax lethal factor is a MAPK kinase protease'
[patent_app_type] => utility
[patent_app_number] => 11/326985
[patent_app_country] => US
[patent_app_date] => 2006-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22258
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234328.pdf
[firstpage_image] =>[orig_patent_app_number] => 11326985
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/326985 | Anthrax lethal factor is a MAPK kinase protease | Jan 4, 2006 | Issued |
Array
(
[id] => 5922596
[patent_doc_number] => 20060240535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Carbonyl reductase from lactococcus lactis'
[patent_app_type] => utility
[patent_app_number] => 11/271585
[patent_app_country] => US
[patent_app_date] => 2005-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10346
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240535.pdf
[firstpage_image] =>[orig_patent_app_number] => 11271585
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/271585 | Carbonyl reductase from lactococcus lactis | Nov 9, 2005 | Abandoned |
Array
(
[id] => 5814061
[patent_doc_number] => 20060084151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Method for producing L-glutamic acid'
[patent_app_type] => utility
[patent_app_number] => 11/265288
[patent_app_country] => US
[patent_app_date] => 2005-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13170
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084151.pdf
[firstpage_image] =>[orig_patent_app_number] => 11265288
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/265288 | Method for producing L-glutamic acid | Nov 2, 2005 | Issued |
Array
(
[id] => 5912920
[patent_doc_number] => 20060127982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Development of an asporogenic bacillus licheniformis and production of keratinase therefrom'
[patent_app_type] => utility
[patent_app_number] => 11/261818
[patent_app_country] => US
[patent_app_date] => 2005-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7219
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127982.pdf
[firstpage_image] =>[orig_patent_app_number] => 11261818
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/261818 | Development of an asporogenic bacillus licheniformis and production of keratinase therefrom | Oct 27, 2005 | Abandoned |
Array
(
[id] => 5808513
[patent_doc_number] => 20060094868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'System for cell-based screening'
[patent_app_type] => utility
[patent_app_number] => 11/252276
[patent_app_country] => US
[patent_app_date] => 2005-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 100
[patent_figures_cnt] => 100
[patent_no_of_words] => 41788
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11252276
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/252276 | System for cell-based screening | Oct 16, 2005 | Abandoned |
Array
(
[id] => 5590905
[patent_doc_number] => 20060040357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/245400
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 106788
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040357.pdf
[firstpage_image] =>[orig_patent_app_number] => 11245400
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/245400 | Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor | Oct 5, 2005 | Issued |
Array
(
[id] => 5776804
[patent_doc_number] => 20060105444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'O-fucosyltransferase'
[patent_app_type] => utility
[patent_app_number] => 11/244452
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 25389
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20060105444.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244452
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244452 | O-fucosyltransferase | Oct 5, 2005 | Abandoned |
Array
(
[id] => 5819921
[patent_doc_number] => 20060024234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Protein markers for pharmaceuticals and related toxicity'
[patent_app_type] => utility
[patent_app_number] => 11/231133
[patent_app_country] => US
[patent_app_date] => 2005-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23810
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11231133
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/231133 | Protein markers for pharmaceuticals and related toxicity | Sep 18, 2005 | Abandoned |
Array
(
[id] => 5767859
[patent_doc_number] => 20060019365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'IKK-alpha proteins, nucleic acids and methods'
[patent_app_type] => utility
[patent_app_number] => 11/222158
[patent_app_country] => US
[patent_app_date] => 2005-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6479
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019365.pdf
[firstpage_image] =>[orig_patent_app_number] => 11222158
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/222158 | IKK-alpha proteins, nucleic acids and methods | Sep 6, 2005 | Abandoned |
Array
(
[id] => 803183
[patent_doc_number] => 07422886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-09
[patent_title] => 'Method for determining modulation of P110Δ activity'
[patent_app_type] => utility
[patent_app_number] => 11/219611
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 12073
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/422/07422886.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219611
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219611 | Method for determining modulation of P110Δ activity | Sep 1, 2005 | Issued |
Array
(
[id] => 5766752
[patent_doc_number] => 20060018892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Human serpin polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/219282
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 36369
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20060018892.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219282
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219282 | Human serpin polypeptides | Sep 1, 2005 | Issued |